Combining HPV and MIB-1 tests reduces the number of colposcopies in women with equivocal cytology

Acta Obstet Gynecol Scand. 2006;85(12):1491-5. doi: 10.1080/00016340600936001.

Abstract

Background: In this study the MIB-1 immunostaining pattern as an index of cellular proliferation was analyzed in smears diagnosed as borderline dyskaryosis in order to establish whether the combination of human papillomavirus testing and MIB-1 staining could resolve equivocal cytology.

Methods: Conventional Pap smears of 108 women diagnosed as borderline dyskaryosis were stained with MIB-1 and the proliferation index was assessed. These women were evaluated by colposcopy, histological sampling, and human papillomavirus, semi-quantitative evaluated by hybrid Capture II test.

Results: All 64 human papillomavirus- and MIB-1-negative women had no underlying high-grade cervical intraepithelial neoplasia or cervical cancer. Forty of the 104 women with normal histology or cervical intraepithelial neoplasia I were positive for human papillomavirus, compared to only one positive MIB-1 test (i.e. proliferation index of more than 35%).

Conclusions: Adding a MIB-1-test in human papillomavirus-positive women with equivocal cytology might reduce the number of colposcopies needed to predict > or = cervical intraepithelial neoplasia II. With this approach only four instead of 43 human papillomavirus-positive women would have been referred for colposcopy.

MeSH terms

  • Antibodies, Antinuclear*
  • Antibodies, Monoclonal*
  • Cell Division
  • Cohort Studies
  • Colposcopy
  • DNA, Viral / analysis
  • Female
  • Humans
  • Ki-67 Antigen / analysis*
  • Ki-67 Antigen / immunology
  • Papanicolaou Test
  • Papillomaviridae / genetics
  • Papillomaviridae / isolation & purification*
  • Papillomavirus Infections / complications
  • Papillomavirus Infections / diagnosis
  • Tumor Virus Infections / diagnosis
  • Tumor Virus Infections / pathology
  • Tumor Virus Infections / virology
  • Uterine Cervical Dysplasia / diagnosis*
  • Uterine Cervical Dysplasia / pathology
  • Uterine Cervical Dysplasia / virology
  • Uterine Cervical Neoplasms / diagnosis*
  • Uterine Cervical Neoplasms / pathology
  • Uterine Cervical Neoplasms / virology
  • Vaginal Smears / methods

Substances

  • Antibodies, Antinuclear
  • Antibodies, Monoclonal
  • DNA, Viral
  • Ki-67 Antigen
  • MIB-1 antibody